- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00315978
The Impact of Patient Involvement in Decision-Making About Heart Disease Prevention
Decision Aid to Improve Coronary Heart Disease Risk Modification: a Pilot Randomized Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Low utilization of effective CHD prevention strategies may be due to many factors, but chief among them is the lack of patient involvement in prevention decisions. We undertook this study to test the effectiveness of an individually-tailored, computerized decision aid about CHD on patients' discussions with their doctor and their plans for CHD prevention.
Methods: We conducted a pilot randomized trial in a convenience sample of adults with no previous history of cardiovascular disease to test the effectiveness of an individually-tailored, computerized decision aid about CHD prevention against a risk factor list that patients could present to their doctor.
Study Type
Enrollment
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- University of North Carolina at Chapel Hill
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- presenting for routine medical care with regular medical provider
- able to understand, speak, and read English
Exclusion Criteria:
- prior history of cardiovascular disease
- history of serious medical illness that would limit candidacy for screening
- previous participation in intensive risk modification as part of diabetes study in our clinic
- no cholesterol measurement in the last 3 years, limiting ability to provide up-to-date risk estimate
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Discussion with provider about CHD risk reduction
|
|
Stated plans for CHD risk reduction
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Knowledge about CHD prevention
|
|
Perception of CHD risk
|
|
Interest in participating in decision-making
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Stacey L. Sheridan, MD, MPH, University of North Carolina, Chapel Hill
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 03-MED-221
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Disease
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingCardiovascular Disease (CVD) | Gender Incongruence | Cardiovascular (CV) Risk | Cardiovascular Health Status | Cardiovascular Disease Prevention | Cardiovascular Disease Acute | Cardiovascular Disease Risk FactorItaly
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Disease | Inflammatory DiseaseUnited States
-
University College DublinBeacon Hospital, IrelandRecruitingCoronary Artery Disease (CAD) | Cardiovascular Diseases (CVD) | Cardiovascular Disease Prevention | Cardiovascular Disease Risk FactorIreland
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Istituti Clinici Scientifici Maugeri SpAA.R.C.A Associazioni Regionali Cardiologi AmbulatorialiRecruiting
-
AmgenRecruitingCardiovascular DiseaseItaly, Germany, United States, China, Japan, Spain, Denmark, Australia, France, Canada, Netherlands
-
University of ReadingBiotechnology and Biological Sciences Research Council; Royal Berkshire NHS...Not yet recruiting
-
Nanjing Medical UniversityRecruiting
-
Centre Hospitalier Universitaire de la RéunionRecruitingCardiovascular DiseaseFrance
Clinical Trials on Heart-to-Heart Decision Aid
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Diseases | Coronary DiseaseUnited States
-
Misook L. ChungCompletedDepression | Heart Failure | Stress | Anxiety | Caregiver BurdenUnited States
-
Seattle Children's HospitalCompletedSexually Transmitted Diseases | Pregnancy Related | Sexual Behavior | Family and Household | Conflict, FamilyUnited States
-
Rush University Medical CenterRecruiting
-
Ajou University School of MedicineCompleted
-
China National Center for Cardiovascular DiseasesThe First Affiliated Hospital with Nanjing Medical University; Ruijin Hospital and other collaboratorsNot yet recruiting
-
University of AmsterdamRadboud University Medical Center; Leiden University Medical CenterNot yet recruitingDecision Aid | Gallstone | Sustainability | Decision Making ,SharedNetherlands
-
New York UniversityNational Institute of Mental Health (NIMH); Beth Israel Medical Center; St. Luke...CompletedHIV | Antiretroviral TherapyUnited States
-
Hospital Sirio-LibanesRecruiting
-
University of South CarolinaCenters for Disease Control and PreventionNot yet recruitingHealthy Participants | Chronic Disease Prevention | Chronic Diseases in Older AdultsUnited States